Correlation Between Acumen Pharmaceuticals and Enviri

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Enviri at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Enviri into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and Enviri, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Enviri and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Enviri. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Enviri.

Diversification Opportunities for Acumen Pharmaceuticals and Enviri

0.19

Correlation Coefficient

Acumen Pharmaceuticals  Enviri

Average diversification

The 3 months correlation between Acumen and Enviri is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Enviri in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enviri and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Enviri. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enviri has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Enviri go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Enviri

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the Enviri. In addition to that, Acumen Pharmaceuticals is 1.78 times more volatile than Enviri. It trades about -0.29 of its total potential returns per unit of risk. Enviri is currently generating about 0.23 per unit of volatility. If you would invest  762.00  in Enviri on October 12, 2024 and sell it today you would earn a total of  81.00  from holding Enviri or generate 10.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  Enviri

Acumen Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Enviri

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enviri has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Acumen Pharmaceuticals and Enviri

The main advantage of trading using opposite Acumen Pharmaceuticals and Enviri positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Enviri can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enviri will offset losses from the drop in Enviri's long position.

The idea behind Acumen Pharmaceuticals and Enviri pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.